[
  {
    "ts": "2025-11-21T00:30:00+00:00",
    "headline": "Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies",
    "summary": "VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) (\"Onco\" or the \"Company\") is pleased to announce that its manufacturing partner, Dalton Pharma Services (\"Dalton\"), ...",
    "url": "https://finance.yahoo.com/news/onco-innovations-advances-optimization-scale-003000580.html",
    "source": "ACCESS Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "e84dbaf9-ba40-3f55-8c27-42cf759c0354",
      "content": {
        "id": "e84dbaf9-ba40-3f55-8c27-42cf759c0354",
        "contentType": "STORY",
        "title": "Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies",
        "description": "",
        "summary": "VANCOUVER, BC / ACCESS Newswire / November 20, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H, WKN:A3EKSZ) (\"Onco\" or the \"Company\") is pleased to announce that its manufacturing partner, Dalton Pharma Services (\"Dalton\"), ...",
        "pubDate": "2025-11-21T00:30:00Z",
        "displayTime": "2025-11-21T00:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "ACCESS Newswire",
          "url": "https://www.accessnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/onco-innovations-advances-optimization-scale-003000580.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/onco-innovations-advances-optimization-scale-003000580.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ONCO.NE"
            },
            {
              "symbol": "W1H.F"
            },
            {
              "symbol": "CBOE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-21T02:16:00+00:00",
    "headline": "Zefiro Founder and Former Chairman Requisitions Shareholders Meeting and intends to Nominate Five Directors to the Board of Directors of Zefiro Methane",
    "summary": "Zefiro’s largest shareholder calls for change to replace self-serving and conflicted board that is destroying shareholder valueTORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) (\"Zefiro\"), today announced that he is nominating five highly qualified candidates for election to Zefiro’s board of directors (the “Board”) at Zefiro’s next annual and special meeting of shareholders (the “Meeting”). Dr. Debs’ nominees include himself,",
    "url": "https://finance.yahoo.com/news/zefiro-founder-former-chairman-requisitions-021600018.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "abd9828f-6bc0-3b7d-ad80-5d0b5fc4c67b",
      "content": {
        "id": "abd9828f-6bc0-3b7d-ad80-5d0b5fc4c67b",
        "contentType": "STORY",
        "title": "Zefiro Founder and Former Chairman Requisitions Shareholders Meeting and intends to Nominate Five Directors to the Board of Directors of Zefiro Methane",
        "description": "",
        "summary": "Zefiro’s largest shareholder calls for change to replace self-serving and conflicted board that is destroying shareholder valueTORONTO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Dr. Talal A. Debs, Founder and Director of Zefiro Methane Corp. (Cboe: ZEFI) (\"Zefiro\"), today announced that he is nominating five highly qualified candidates for election to Zefiro’s board of directors (the “Board”) at Zefiro’s next annual and special meeting of shareholders (the “Meeting”). Dr. Debs’ nominees include himself,",
        "pubDate": "2025-11-21T02:16:00Z",
        "displayTime": "2025-11-21T02:16:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zefiro-founder-former-chairman-requisitions-021600018.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zefiro-founder-former-chairman-requisitions-021600018.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ZEFI.NE"
            },
            {
              "symbol": "ZEFIF"
            },
            {
              "symbol": "CBOE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]